首页> 外国专利> THERAPY ANTAGONIST OF OXYTOCIN RECEPTORS INTO LUTE PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN THROUGH PROCEDURES OF AUXILIARY REPRODUCTIVE TECHNOLOGIES

THERAPY ANTAGONIST OF OXYTOCIN RECEPTORS INTO LUTE PHASE FOR IMPLANTATION AND PREGNANCY IN WOMEN THROUGH PROCEDURES OF AUXILIARY REPRODUCTIVE TECHNOLOGIES

机译:通过辅助生殖技术使催产素受体在女人体内浸润和妊娠的治疗拮抗剂

摘要

The present invention relates to the use of the oxytocin receptor antagonist in women undergoing embryo transfer within assisted reproductive technologies. In particular, methods have been proposed for increasing the frequency of ongoing implantation, increasing the frequency of continuing pregnancy, increasing the frequency of clinical pregnancy and / or increasing the frequency of live births in female subjects undergoing embryo transfer. In particular, antagonist release occurs in the luteal phase when the endometrium is susceptible to embryo implantation and / or when the embryo has reached the blastocyst stage.
机译:本发明涉及催产素受体拮抗剂在辅助生殖技术中进行胚胎移植的妇女中的用途。特别地,已经提出了用于在进行胚胎移植的女性受试者中增加正在进行的植入的频率,增加持续妊娠的频率,增加临床妊娠的频率和/或增加活产的频率的方法。特别地,当子宫内膜易于胚胎植入和/或胚胎达到胚泡期时,拮抗剂释放发生在黄体期。

著录项

  • 公开/公告号EA201791361A1

    专利类型

  • 公开/公告日2017-11-30

    原文格式PDF

  • 申请/专利权人 ФЕРРИНГ Б.В.;

    申请/专利号EA20170091361

  • 发明设计人 ХОАН-КАРЛЕС;

    申请日2015-12-21

  • 分类号A61K38/08;A61P15/08;

  • 国家 EA

  • 入库时间 2022-08-21 12:52:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号